Related Experiment Videos
Cannabinoids and brain injury: therapeutic implications
Raphael Mechoulam1, David Panikashvili, Esther Shohami
1Dept of Medicinal Chemistry and Natural Products, Medical Faculty, Hebrew University, Jerusalem 91120, Israel. mechou@cc.huji.ac.il
Trends in Molecular Medicine
|January 30, 2002
Summary
Cannabinoids, including endocannabinoids and plant-based compounds, show neuroprotective potential after brain injury by reducing neuronal damage. These substances may mitigate secondary injury effects, offering therapeutic promise.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Endocannabinoids (anandamide and 2-arachidonoyl glycerol) and other cannabinoids demonstrate neuroprotective properties in preclinical models.
- Brain injury triggers increased endocannabinoid production, suggesting a role in endogenous neuroprotection.
Purpose of the Study:
- To review the neuroprotective effects of endocannabinoids and other cannabinoids following brain injury.
- To explore the mechanisms underlying cannabinoid-mediated neuroprotection.
Main Methods:
- Review of in vitro and in vivo studies on cannabinoid neuroprotection.
- Analysis of data on cannabinoid receptor agonism and non-cannabinoid receptor-mediated effects.
Main Results:
- Cannabinoid receptor agonists reduce excitotoxicity by inhibiting glutamatergic transmission.
- Cannabinoids decrease the production of inflammatory mediators like tumor necrosis factor-alpha and reactive oxygen species.
- Endogenous cannabinoids are upregulated post-injury and may limit secondary damage.
- Some non-cannabinoid receptor-binding cannabinoids also exhibit neuroprotection via glutamate modulation or antioxidant activity.
Conclusions:
- Cannabinoids represent a promising therapeutic strategy for mitigating neuronal damage after brain injury.
- Both receptor-dependent and independent mechanisms contribute to cannabinoid neuroprotection.